Copyright
©The Author(s) 2021.
World J Cardiol. May 26, 2021; 13(5): 130-143
Published online May 26, 2021. doi: 10.4330/wjc.v13.i5.130
Published online May 26, 2021. doi: 10.4330/wjc.v13.i5.130
Table 7 Pearson’s correlation
Parameter | CHOL | LDL-C | HDL-C | TG | hsCRP | HC | sRAGE | Lp (a) |
CHOL | 1 | 0.865b | −0.616b | 0.491b | 0.052 | 0.090 | −0.179 | 0.227 |
LDL−C | 0.865b | 1 | −0.606b | 0.646b | 0.082 | 0.094 | −0.197 | 0.205 |
HDL−C | −0.616b | −0.606b | 1 | −0.529b | −0.157 | −0.164 | 0.245 | −0.169 |
TG | 0.491b | 0.646b | −0.529b | 1 | −0.182 | −0.002 | −0.127 | 0.174 |
hsCRP | 0.052 | 0.082 | −0.157 | −0.182 | 1 | 0.761b | 0.011 | −0.235 |
HC | 0.090 | 0.094 | −0.164 | −0.002 | 0.761b | 1 | 0.067 | −0.226 |
sRAGE | −0.179 | −0.197 | 0.245 | −0.127 | 0.011 | 0.067 | 1 | 0.158 |
Lp(a) | 0.227 | 0.205 | −0.169 | 0.174 | −0.235 | −0.226 | 0.158 | 1 |
- Citation: Ghosh S, Kapoor D, Vijayvergiya R, Sangwan S, Wangkheimayum S, Mehta S, Dhawan V. Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women. World J Cardiol 2021; 13(5): 130-143
- URL: https://www.wjgnet.com/1949-8462/full/v13/i5/130.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i5.130